{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T15:00:00Z","timestamp":1784818800365,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.rmed.2012.08.014","type":"journal-article","created":{"date-parts":[[2012,9,11]],"date-time":"2012-09-11T01:30:33Z","timestamp":1347327033000},"page":"1810-1813","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Infliximab therapy modulates an antigen-specific immune response in chronic beryllium disease"],"prefix":"10.1016","volume":"106","author":[{"given":"Lisa A.","family":"Maier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Briana Q.","family":"Barkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Mroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milton D.","family":"Rossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Barnard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May","family":"Gillespie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas G.","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Silveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard T.","family":"Sawyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee S.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"Fontenot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2012.08.014_bib1","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1080\/15459620490502233","article-title":"Industries in the United States with airborne beryllium exposure and estimates of the number of current workers potentially exposed","volume":"1","author":"Henneberger","year":"2004","journal-title":"J Occup Environ Hyg"},{"key":"10.1016\/j.rmed.2012.08.014_bib2","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/ACI.0b013e3282f824a4","article-title":"Immunology of chronic beryllium disease","volume":"8","author":"Samuel","year":"2008","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.rmed.2012.08.014_bib3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ajim.20140","article-title":"Process-related risk of beryllium sensitization and disease in a copper\u2013beryllium alloy facility","volume":"47","author":"Schuler","year":"2005","journal-title":"Am J Ind Med"},{"key":"10.1016\/j.rmed.2012.08.014_bib4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s004200100237","article-title":"Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant","volume":"74","author":"Henneberger","year":"2001","journal-title":"Int Arch Occup Environ Health"},{"key":"10.1016\/j.rmed.2012.08.014_bib5","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1164\/ajrccm.155.6.9196114","article-title":"Observer variation and relationship of computed tomography to severity of beryllium disease","volume":"155","author":"Daniloff","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.rmed.2012.08.014_bib6","first-page":"1","article-title":"Long-term follow-up of beryllium sensitized workers from a single employer","volume":"10","author":"Duggal","year":"2010","journal-title":"BMC Public Health"},{"issue":"10","key":"10.1016\/j.rmed.2012.08.014_bib7","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/ajim.20736","article-title":"Beryllium lymphocyte proliferation test surveillance identifies clinically significant beryllium disease","volume":"52","author":"Mroz","year":"2009","journal-title":"Am J Ind Med"},{"key":"10.1016\/j.rmed.2012.08.014_bib8","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1164\/rccm.200402-190OC","article-title":"Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study","volume":"171","author":"Newman","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2012.08.014_bib9","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1164\/ajrccm\/148.3.661","article-title":"Early pulmonary physiologic abnormalities in beryllium disease","volume":"148","author":"Pappas","year":"1993","journal-title":"Am Rev Respir Dis"},{"issue":"3","key":"10.1016\/j.rmed.2012.08.014_bib10","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1183\/09031936.00149607","article-title":"Short- and long-term response to corticosteroid therapy in chronic beryllium disease","volume":"32","author":"Marchand-Adam","year":"2008","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.rmed.2012.08.014_bib11","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1378\/chest.126.6.2000","article-title":"Variable response to long-term corticosteroid therapy in chronic beryllium disease","volume":"126","author":"Sood","year":"2004","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.rmed.2012.08.014_bib12","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/jama.287.10.1301","article-title":"Corticosteroid therapy in pulmonary sarcoidosis: a systematic review","volume":"287","author":"Paramothayan","year":"2002","journal-title":"J Am Med Assoc"},{"issue":"3","key":"10.1016\/j.rmed.2012.08.014_bib13","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/thx.51.3.238","article-title":"British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment","volume":"51","author":"Gibson","year":"1996","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2012.08.014_bib14","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1136\/thx.54.8.742","article-title":"A clinical approach to the use of methotrexate for sarcoidosis","volume":"54","author":"Baughman","year":"1999","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.rmed.2012.08.014_bib15","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0272-5231(05)70423-8","article-title":"Steroid-sparing alternative treatments for sarcoidosis","volume":"18","author":"Baughman","year":"1997","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.rmed.2012.08.014_bib16","first-page":"A146","article-title":"Methotrexate treatment in chronic beryllium disease","volume":"157","author":"Daniloff","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2012.08.014_bib17","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1164\/rccm.200603-402OC","article-title":"Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement","volume":"174","author":"Baughman","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2012.08.014_bib18","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1164\/ajrccm.164.7.2012123","article-title":"High beryllium-stimulated TNF-alpha is associated with the \u2212308 TNF-alpha promoter polymorphism and with clinical severity in chronic beryllium disease","volume":"164","author":"Maier","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2012.08.014_bib19","first-page":"A2255","article-title":"Infliximab reverses Peripheral CD4+ T cell depletion in lymphopenic sarcoidosis patients","volume":"179","author":"Crouser","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.rmed.2012.08.014_bib20","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1084\/jem.20040165","article-title":"Compromised function of regulatory T cells n rheumatoid arthritis and reversal by ANti-TNF alpha therapy","volume":"200","author":"Ehrenstein","year":"2004","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.rmed.2012.08.014_bib21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1084\/jem.20061531","article-title":"Anti\u2013TNF-\u03b1 therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-\u03b2","volume":"204","author":"Nadkarni","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.rmed.2012.08.014_bib22","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1164\/rccm.201001-0025OC","article-title":"Deficient and dysfunctional regulatory T cells in the lungs of chronic beryllium disease subjects","volume":"181","author":"Mack","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2012.08.014_bib23","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","article-title":"Maintenance infliximab for Crohn's disease: the ACCENT I randomised trail","volume":"359","author":"Hanauer","year":"2002","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.rmed.2012.08.014_bib24","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJMoa030815","article-title":"Infliximab maintenance therapy for fistulizing Crohn's disease","volume":"350","author":"Sands","year":"2004","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.rmed.2012.08.014_bib25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1572-0241.2003.04010.x","article-title":"Remission in patients with Crohn's disease is associated with improvement in employment and quality of life and a decrease in hospitalizations and surgeries","volume":"99","author":"Lichtenstein","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"22","key":"10.1016\/j.rmed.2012.08.014_bib26","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJM200011303432202","article-title":"INfliximab and MEthotrexate in the treatment of rheumatoid arthritis","volume":"343","author":"Lipsky","year":"2000","journal-title":"N Engl J Med"},{"issue":"R103","key":"10.1016\/j.rmed.2012.08.014_bib27","first-page":"1","article-title":"The impact of infliximab treatment on quality of life in patients with inflammatory rheumatic diseases","volume":"9","author":"Han","year":"2007","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.rmed.2012.08.014_bib28","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1136\/ard.2005.040196","article-title":"Infliximab improves health related quality of life and physical function in patients with psoriatic arthritis","volume":"65","author":"Kavanaugh","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rmed.2012.08.014_bib29","doi-asserted-by":"crossref","first-page":"a3006","DOI":"10.1136\/bmj.a3006","article-title":"Reporting and interpretation of SF-36 outcomes in randomised trials: systematic review","volume":"338","author":"Contopoulos-Ioannidis","year":"2009","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.rmed.2012.08.014_bib30","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1002\/art.11024","article-title":"Predicting mortality in patients with rheumatoid arthritis","volume":"48","author":"Wolfe","year":"2003","journal-title":"Arthritis Rheum"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611112003101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611112003101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:26:00Z","timestamp":1760613960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611112003101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0954611112003101"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2012.08.014","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infliximab therapy modulates an antigen-specific immune response in chronic beryllium disease","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2012.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}